Cite
A randomized phase 2 study on demeclocycline in patients with mild-to-moderate COVID-19
MLA
Kota Iwahori, et al. “A Randomized Phase 2 Study on Demeclocycline in Patients with Mild-to-Moderate COVID-19.” Scientific Reports, vol. 13, no. 1, Aug. 2023, pp. 1–11. EBSCOhost, https://doi.org/10.1038/s41598-023-41051-2.
APA
Kota Iwahori, Takuro Nii, Norihiko Yamaguchi, Takahiro Kawasaki, Satomi Okamura, Kazuki Hashimoto, Takanori Matsuki, Kazuyuki Tsujino, Keisuke Miki, Akio Osa, Sho Goya, Kinya Abe, Masahide Mori, Yoshito Takeda, Tomomi Yamada, Hiroshi Kida, & Atsushi Kumanogoh. (2023). A randomized phase 2 study on demeclocycline in patients with mild-to-moderate COVID-19. Scientific Reports, 13(1), 1–11. https://doi.org/10.1038/s41598-023-41051-2
Chicago
Kota Iwahori, Takuro Nii, Norihiko Yamaguchi, Takahiro Kawasaki, Satomi Okamura, Kazuki Hashimoto, Takanori Matsuki, et al. 2023. “A Randomized Phase 2 Study on Demeclocycline in Patients with Mild-to-Moderate COVID-19.” Scientific Reports 13 (1): 1–11. doi:10.1038/s41598-023-41051-2.